Going to extremes: progress in exploring new environments for novel antibiotics
Top Cited Papers
Open Access
- 25 March 2024
- journal article
- review article
- Published by Springer Nature in npj Antimicrobials and Resistance
- Vol. 2 (1) , 1-9
Abstract
The discoveries of penicillin and streptomycin were pivotal for infection control with the knowledge subsequently being used to enable the discovery of many other antibiotics currently used in clinical practice. These valuable compounds are generally derived from mesophilic soil microorganisms, predominantly Streptomyces species. Unfortunately, problems with the replication of results suggested that this discovery strategy was no longer viable, motivating a switch to combinatorial chemistry in conjunction with existing screening programmes to derive new antimicrobials. However, the chemical space occupied by these synthetic products is vastly reduced compared to those of natural products. More recent approaches such as using artificial intelligence to ‘design’ synthetic ligands to dock with molecular targets suggest that chemical synthesis is still a promising option for discovery. It is important to employ diverse discovery strategies to combat the worrying increase in antimicrobial resistance (AMR). Here, we reconsider whether nature can supply innovative solutions to recalcitrant infections. Specifically, we assess progress in identifying novel antibiotic-producing organisms from extreme and unusual environments. Many of these organisms have adapted physiologies which often means they produce different repertoires of bioactive metabolites compared to their mesophilic counterparts, including antibiotics. In addition, we examine insights into the regulation of extremotolerant bacterial physiologies that can be harnessed to increase the production of clinically important antibiotics and stimulate the synthesis of new antibiotics in mesophilic microorganisms. Finally, we comment on the insights provided by combinatorial approaches to the treatment of infectious diseases that might enhance the efficacy of antibiotics and reduce the development of AMR.Keywords
This publication has 88 references indexed in Scilit:
- Characterization of anti-BCG benz[α]anthraquinones and new siderophores from a Xinjiang desert–isolated rare actinomycete Nocardia sp. XJ31Applied Microbiology and Biotechnology, 2020
- A new acyclic peroxide from Aspergillus nidulans SD-531, a fungus obtained from deep-sea sediment of cold spring in the South China SeaJournal of Oceanology and Limnology, 2020
- Antimicrobial compounds from marine actinomycetesArchives of Pharmacal Research, 2020
- Identification of a Sorbicillinoid-Producing Aspergillus Strain with Antimicrobial Activity Against Staphylococcus aureus: a New Polyextremophilic Marine Fungus from Barents SeaMarine Biotechnology, 2018
- Natural product diversity of actinobacteria in the Atacama DesertAntonie van Leeuwenhoek, 2018
- Profiling of red pigment produced by Streptomyces sp. JAR6 and its bioactivity3 Biotech, 2017
- Stress-driven discovery of a cryptic antibiotic produced by Streptomyces sp. WU20 from Kueishantao hydrothermal vent with an integrated metabolomics strategyApplied Microbiology and Biotechnology, 2016
- How many antibiotics are produced by the genus Streptomyces ?Archives of Microbiology, 2001
- Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Sideromycins1967